Literature DB >> 27404029

Characterizing the trajectories of vasomotor symptoms across the menopausal transition.

Ping G Tepper1, Maria M Brooks, John F Randolph, Sybil L Crawford, Samar R El Khoudary, Ellen B Gold, Bill L Lasley, Bobby Jones, Hadine Joffe, Rachel Hess, Nancy E Avis, Sioban Harlow, Daniel S McConnell, Joyce T Bromberger, Huiyong Zheng, Kristine Ruppert, Rebecca C Thurston.   

Abstract

OBJECTIVE: The aim of the study was to investigate the heterogeneity of temporal patterns of vasomotor symptoms (VMS) over the menopausal transition and identify factors associated with these patterns in a diverse sample of women.
METHODS: The Study of Women's Health Across the Nation is a multisite longitudinal study of women from five racial/ethnic groups transitioning through the menopause. The analytic sample included 1,455 women with nonsurgical menopause and a median follow-up of 15.4 years. Temporal patterns of VMS and associations with serum estradiol and follicle-stimulating hormone, race/ethnicity, body mass index, and demographic and psychosocial factors were examined using group-based trajectory modeling.
RESULTS: Four distinct trajectories of VMS were found: onset early (11 years before the final menstrual period) with decline after menopause (early onset, 18.4%), onset near the final menstrual period with later decline (late onset, 29.0%), onset early with persistently high frequency (high, 25.6%), and persistently low frequency (low, 27.0%). Relative to women with persistently low frequency of VMS, women with persistently high and early onset VMS had a more adverse psychosocial and health profile. Black women were overrepresented in the late onset and high VMS subgroups relative to white women. Obese women were underrepresented in the late onset subgroup. In multivariable models, the pattern of estradiol over the menopause was significantly associated with the VMS trajectory.
CONCLUSIONS: These data distinctly demonstrate heterogeneous patterns of menopausal symptoms that are associated with race/ethnicity, reproductive hormones, premenopause body mass index, and psychosocial characteristics. Early targeted intervention may have a meaningful impact on long-term VMS.

Entities:  

Mesh:

Year:  2016        PMID: 27404029      PMCID: PMC5028150          DOI: 10.1097/GME.0000000000000676

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  36 in total

Review 1.  The role of serotonin in hot flushes.

Authors:  H H Berendsen
Journal:  Maturitas       Date:  2000-10-31       Impact factor: 4.342

2.  "MENOPAUSAL SYMPTOMS" IN WOMEN OF VARIOUS AGES.

Authors:  B L NEUGARTEN; R J KRAINES
Journal:  Psychosom Med       Date:  1965 May-Jun       Impact factor: 4.312

3.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

4.  The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.

Authors:  John F Randolph; MaryFran Sowers; Irina Bondarenko; Ellen B Gold; Gail A Greendale; Joyce T Bromberger; Sarah E Brockwell; Karen A Matthews
Journal:  J Clin Endocrinol Metab       Date:  2005-09-06       Impact factor: 5.958

5.  Vasomotor symptoms and cardiovascular events in postmenopausal women.

Authors:  Emily D Szmuilowicz; JoAnn E Manson; Jacques E Rossouw; Barbara V Howard; Karen L Margolis; Nancy C Greep; Robert G Brzyski; Marcia L Stefanick; Mary Jo O'Sullivan; Chunyuan Wu; Matthew Allison; Diederick E Grobbee; Karen C Johnson; Judith K Ockene; Beatriz L Rodriguez; Gloria E Sarto; Mara Z Vitolins; Ellen W Seely
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

6.  How well do different measurement modalities estimate the number of vasomotor symptoms? Findings from the Study of Women's Health Across the Nation FLASHES Study.

Authors:  Polly Fu; Karen A Matthews; Rebecca C Thurston
Journal:  Menopause       Date:  2014-02       Impact factor: 2.953

7.  The amplification of somatic symptoms.

Authors:  A J Barsky; J D Goodson; R S Lane; P D Cleary
Journal:  Psychosom Med       Date:  1988 Sep-Oct       Impact factor: 4.312

8.  Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Joyce T Bromberger; Rachel Hess; Karen A Matthews; Marcia Ory; Miriam Schocken
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

Review 9.  Steroid endocrinology after the menopause: a review.

Authors:  J D Hutton; H S Jacobs; V H James
Journal:  J R Soc Med       Date:  1979-11       Impact factor: 18.000

10.  Changes in body mass index by birth cohort in Japanese adults: results from the National Nutrition Survey of Japan 1956-2005.

Authors:  Ikuko Funatogawa; Takashi Funatogawa; Mutsuhiro Nakao; Kanae Karita; Eiji Yano
Journal:  Int J Epidemiol       Date:  2008-09-09       Impact factor: 7.196

View more
  24 in total

1.  Association of vasomotor symptoms and sleep apnea risk in midlife women.

Authors:  Catherine C Gao; Ekta Kapoor; Melissa C Lipford; Virginia M Miller; Darrell R Schroeder; Kristin C Mara; Stephanie S Faubion
Journal:  Menopause       Date:  2018-04       Impact factor: 2.953

Review 2.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 3.  An update on hormone therapy in postmenopausal women: mini-review for the basic scientist.

Authors:  Virginia M Miller; S Mitchell Harman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-11       Impact factor: 4.733

4.  Monthly variation of hot flashes, night sweats, and trouble sleeping: effect of season and proximity to the final menstrual period (FMP) in the SWAN Menstrual Calendar substudy.

Authors:  Siobán D Harlow; Michael R Elliott; Irina Bondarenko; Rebecca C Thurston; Elizabeth A Jackson
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

Review 5.  Sleep and Sleep Disorders in the Menopausal Transition.

Authors:  Fiona C Baker; Laura Lampio; Tarja Saaresranta; Päivi Polo-Kantola
Journal:  Sleep Med Clin       Date:  2018-09

6.  Sleep Trajectories Before and After the Final Menstrual Period in The Study of Women's Health Across the Nation (SWAN).

Authors:  Howard M Kravitz; Imke Janssen; Joyce T Bromberger; Karen A Matthews; Martica H Hall; Kristine Ruppert; Hadine Joffe
Journal:  Curr Sleep Med Rep       Date:  2017-08-05

7.  The longitudinal relation of inflammation to incidence of vasomotor symptoms.

Authors:  Ellen B Gold; Guibo Xing; Nancy E Avis; Sioban Harlow; Hadine Joffe; Karen Matthews; Jelena M Pavlovic; Rebecca C Thurston; Elaine Waetjen
Journal:  Menopause       Date:  2022-08-01       Impact factor: 3.310

8.  What's in a name: are menopausal "hot flashes" a symptom of menopause or a manifestation of neurovascular dysregulation?

Authors:  Virginia M Miller; Juliana M Kling; Julia A Files; Michael J Joyner; Ekta Kapoor; Ann M Moyer; Walter A Rocca; Stephanie S Faubion
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

9.  Vasomotor Symptoms and Accelerated Epigenetic Aging in the Women's Health Initiative (WHI).

Authors:  Rebecca C Thurston; Judith E Carroll; Morgan Levine; Yuefang Chang; Carolyn Crandall; JoAnn E Manson; Lubna Pal; Lifang Hou; Aladdin H Shadyab; Steve Horvath
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

10.  Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter?

Authors:  Saad Samargandy; Karen A Matthews; Maria M Brooks; Emma Barinas-Mitchell; Jared W Magnani; Rebecca C Thurston; Samar R El Khoudary
Journal:  Circ Res       Date:  2022-01-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.